Wall Street brokerages predict that Teligent Inc (NASDAQ:TLGT) will announce ($0.02) earnings per share for the current fiscal quarter, according to Zacks Investment Research. Two analysts have issued estimates for Teligent’s earnings, with the lowest EPS estimate coming in at ($0.04) and the highest estimate coming in at $0.01. Teligent posted earnings per share of ($0.06) during the same quarter last year, which suggests a positive year-over-year growth rate of 66.7%. The company is scheduled to report its next quarterly earnings report on Thursday, March 21st.
On average, analysts expect that Teligent will report full year earnings of ($0.12) per share for the current financial year, with EPS estimates ranging from ($0.14) to ($0.09). For the next year, analysts expect that the business will report earnings of $0.04 per share, with EPS estimates ranging from ($0.07) to $0.15. Zacks’ earnings per share averages are a mean average based on a survey of sell-side analysts that cover Teligent.
Teligent (NASDAQ:TLGT) last posted its quarterly earnings results on Tuesday, November 13th. The company reported ($0.01) earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of ($0.01). Teligent had a negative return on equity of 44.64% and a negative net margin of 54.17%. The business had revenue of $18.29 million for the quarter, compared to the consensus estimate of $19.80 million.
A number of equities analysts have recently issued reports on TLGT shares. ValuEngine downgraded Teligent from a “buy” rating to a “hold” rating in a research report on Tuesday, October 2nd. Canaccord Genuity decreased their price target on Teligent from $4.00 to $3.00 and set a “hold” rating for the company in a research note on Friday, November 16th.
Large investors have recently made changes to their positions in the company. Virtu Financial LLC purchased a new position in shares of Teligent in the third quarter worth about $172,000. Raymond James Financial Services Advisors Inc. grew its holdings in Teligent by 83.9% in the second quarter. Raymond James Financial Services Advisors Inc. now owns 94,443 shares of the company’s stock valued at $327,000 after purchasing an additional 43,091 shares during the period. Wells Fargo & Company MN grew its holdings in Teligent by 15.9% in the third quarter. Wells Fargo & Company MN now owns 123,329 shares of the company’s stock valued at $488,000 after purchasing an additional 16,919 shares during the period. Bridgeway Capital Management Inc. grew its holdings in Teligent by 112.7% in the third quarter. Bridgeway Capital Management Inc. now owns 283,081 shares of the company’s stock valued at $1,118,000 after purchasing an additional 150,000 shares during the period. Finally, Northpointe Capital LLC acquired a new stake in Teligent in the third quarter valued at approximately $2,948,000. Hedge funds and other institutional investors own 67.75% of the company’s stock.
TLGT opened at $1.42 on Wednesday. Teligent has a 12-month low of $1.13 and a 12-month high of $4.52. The company has a debt-to-equity ratio of 3.30, a quick ratio of 0.86 and a current ratio of 1.31. The firm has a market cap of $76.36 million, a PE ratio of -7.47 and a beta of 1.39.
Teligent, Inc, a specialty generic pharmaceutical company, develops, manufactures, and markets generic topical, branded generic, and generic injectable pharmaceutical products in the United States and Canada. The company sells generic pharmaceutical products in topical, injectable, complex, and ophthalmic dosage forms.
See Also: How to interpret a stock’s beta number
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Teligent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teligent and related companies with MarketBeat.com's FREE daily email newsletter.